Showing results (2131-2140 of 2,268) with videos related to
Sort By:
Pageof 227
Therapeutic Advances in Endocrinology and Metabolism|May 25, 2026
NT-proBNP and its association with autonomous aldosterone production in primary aldosteronismNo-Ting Lin, Cheng-Hsuan Tsai, Yu-Ching Chang, et al.International Journal of Medical Sciences|May 26, 2015
The Association between Glomerular Hyperfiltration and Left Ventricular Structure and Function in Patients with Primary AldosteronismMin-Tsun Liao, Xue-Ming Wu, Chin-Chen Chang, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Defining the priority of using 18F-FDG PET for recurrent cervical cancerTzu-Chen Yen, Lai-Chu See, Ting-Chang Chang, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
Hypoxia-induced metastatic heterogeneity in pancreatic cancerPradeep Moon Gunasekaran, Qianqian Wang, Yoke-Chen Chang, et al.The Lancet. Oncology|March 29, 2012
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trialJames Chih-Hsin Yang, Jin-Yuan Shih, Wu-Chou Su, et al.American Journal of Respiratory and Critical Care Medicine|July 19, 2014
Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancerChun-Chieh Chen, Hsuan-Yu Chen, Kang-Yi Su, et al.Journal of Biomedical Science|February 5, 2016
Fanconi anemia genes in lung adenocarcinoma- a pathway-wide study on cancer susceptibilityShi-Yi Yang, Chia-Ni Hsiung, Yao-Jen Li, et al.Biomedicines|November 26, 2022
Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy EraWing-Keen Yap, Ming-Chieh Shih, Yu-Chen Chang, et al.Lung Cancer (Amsterdam, Netherlands)|February 14, 2026
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysisHidetoshi Hayashi, Byoung Chul Cho, Yu Jung Kim, et al.Clinical Lung Cancer|November 27, 2025
Savolitinib Plus Osimertinib in Epidermal Growth Factor-Mutated, MET-Amplified Advanced Non-Small Cell Lung Cancer: A Randomized Phase II trialJames Chih-Hsin Yang, Yuh-Min Chen, Ullas Batra, et al.Pageof 227